Cargando…
Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model
Alzheimer's disease (AD) is the most common neurodegenerative disease nowadays that causes memory impairments. It is characterized by extracellular aggregates of amyloid-beta (Aβ), intracellular aggregates of hyperphosphorylated Tau (p-Tau), and other pathological features. Trilobatin (TLB), a...
Autores principales: | Ding, Jiuyang, Huang, Jian, Yin, Dan, Liu, Ting, Ren, Zheng, Hu, Shanshan, Ye, Yuanliang, Le, Cuiyun, Zhao, Na, Zhou, Hongmei, Li, Zhu, Qi, Xiaolan, Huang, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589506/ https://www.ncbi.nlm.nih.gov/pubmed/34777683 http://dx.doi.org/10.1155/2021/3298400 |
Ejemplares similares
-
Inflammasome Inhibition Prevents Motor Deficit and Cerebellar Degeneration Induced by Chronic Methamphetamine Administration
por: Ding, Jiuyang, et al.
Publicado: (2022) -
Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer’s disease
por: Liu, Li-Fen, et al.
Publicado: (2023) -
Luteolin Ameliorates Methamphetamine-Induced Podocyte Pathology by Inhibiting Tau Phosphorylation in Mice
por: Ding, Jiuyang, et al.
Publicado: (2022) -
Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer’s disease
por: Ou, Zihao, et al.
Publicado: (2020) -
Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer’s-Type Tau Pathology
por: Cho, Joshua D., et al.
Publicado: (2021)